Top Stock Gainers Today July 16, 2026 —>> Wednesday’s trading session highlighted strong gains in healthcare and pharmaceutical stocks despite weakness across major technology shares. While the Nasdaq 100 declined 1.51% and semiconductor stocks retreated, investors rotated into companies reporting strong earnings and positive corporate developments.
Abbott Laboratories led the session’s large-cap gainers following better-than-expected quarterly results, while AtaiBeckley surged after reports that Eli Lilly was nearing an acquisition agreement.
Wednesday Market Summary
| Index | Close | Change |
|---|---|---|
| S&P 500 | ~7,481 | -0.45% |
| Nasdaq 100 | — | -1.51% |
| Dow Jones | 52,552.97 | -105.67 (-0.23%) |
| Russell 2000 | — | -0.23% |
| Healthcare Sector (XLV) | — | Outperformed |
| Technology Sector (XLK) | — | Underperformed |
10 Top Stock Gainers Today – Wednesday, July 16, 2026
1. Abbott Laboratories (ABT) – +10.70%
Abbott Laboratories was Wednesday’s top large-cap performer after reporting second-quarter results that exceeded Wall Street expectations.
The company also raised its full-year guidance, helping shares climb more than 10%.
Key Metrics
| Metric | Value |
|---|---|
| Closing Price | $98.82 |
| Daily Gain | +10.70% (+$9.55) |
| Q2 Results | Beat revenue, EPS, and guidance |
| Key Business Segments | Diagnostics, Medical Devices, Cardiovascular |
| FreeStyle Libre | Continued global expansion |
| Next Catalyst | Full Q2 earnings call |
Abbott benefited from strong performance across its diagnostics, medical device, and cardiovascular businesses.
2. AtaiBeckley (ATAI) – +32.93%
AtaiBeckley posted one of the session’s biggest gains after reports that Eli Lilly was nearing an acquisition agreement.
Key Metrics
| Metric | Value |
|---|---|
| Closing Price | $7.13 |
| Daily Gain | +32.93% |
| Premarket Gain | +62% |
| Drug Focus | DMT-based therapy for treatment-resistant depression |
| Clinical Stage | Phase 3 |
| Potential Acquirer | Eli Lilly |
| Deal Status | Pending final terms |
The news also boosted other companies operating in the psychedelic medicine sector.
3. UnitedHealth Group (UNH) – +4.27%
UnitedHealth gained after reporting quarterly earnings that exceeded analyst expectations and raising full-year guidance.
Key Metrics
| Metric | Value |
|---|---|
| Closing Price | $436.38 |
| Daily Gain | +4.27% |
| Intraday Gain | Up to 7% |
| Adjusted EPS | $6.38 |
| Consensus EPS | $4.85–$4.90 |
| EPS Beat | +$1.53 (31.5%) |
| Revenue | $112.0 billion |
| Revenue Estimate | $110.76–$110.85 billion |
| Full-Year Guidance | Raised |
The company’s results eased investor concerns surrounding medical care costs and managed care profitability.
4. 3M Company (MMM) – +3.70%
3M was the strongest performer in the Dow Jones Industrial Average following a positive restructuring update.
Key Metrics
| Metric | Value |
|---|---|
| Closing Price | $148.62 |
| Daily Gain | +3.70% |
| Catalyst | Operational restructuring update |
| Sector | Industrials |
Investors responded positively to continued progress in the company’s restructuring efforts.
5. GH Research (GHRS) – +19%
GH Research rallied alongside other psychedelic medicine companies following the AtaiBeckley acquisition news.
Key Metrics
| Metric | Value |
|---|---|
| Daily Gain | +19% |
| Drug Pipeline | 5-MeO-DMT |
| Clinical Stage | Phase 2b/3 |
| Market Theme | Psychedelic medicine |
The broader sector benefited as investors reassessed growth opportunities within psychedelic therapies.
6. Compass Pathways (CMPS) – +7%
Compass Pathways also moved higher during the session.
Key Metrics
| Metric | Value |
|---|---|
| Daily Gain | +7% |
| Lead Program | COMP360 psilocybin therapy |
| Target Market | Treatment-resistant depression |
The stock gained as positive sentiment spread throughout the psychedelic healthcare sector.
7. Johnson & Johnson (JNJ) – +1.61%
Johnson & Johnson participated in the healthcare rally.
Key Metrics
| Metric | Value |
|---|---|
| Closing Price | $227.63 |
| Daily Gain | +1.61% |
The company continued benefiting from strength across its pharmaceutical and medical technology businesses.
8. Nvidia (NVDA) – +1.77%
Nvidia outperformed the broader technology sector despite weakness across semiconductor stocks.
Key Metrics
| Metric | Value |
|---|---|
| Closing Price | $225.01 |
| Daily Gain | +1.77% |
The company remained supported by continued demand for AI infrastructure.
9. Cisco Systems (CSCO) – +1.33%
Cisco gained as investors rotated toward established technology infrastructure companies.
Key Metrics
| Metric | Value |
|---|---|
| Daily Gain | +1.33% |
| Sector | Networking and Enterprise Infrastructure |
Cisco benefited from continued interest in enterprise AI infrastructure.
10. Eli Lilly (LLY)
Eli Lilly received investor attention following reports that it was pursuing the acquisition of AtaiBeckley.
Key Highlights
| Metric | Value |
|---|---|
| Catalyst | Proposed AtaiBeckley acquisition |
| Strategic Focus | Expansion into psychedelic therapies |
| Industry | Pharmaceuticals |
The reported transaction highlighted Eli Lilly’s interest in expanding its mental health treatment pipeline.
Wednesday’s Market Theme
Wednesday’s market highlighted a clear rotation toward healthcare companies reporting strong earnings and positive business developments.
Key themes included:
- Abbott’s strong earnings and raised guidance.
- UnitedHealth’s significant earnings beat.
- Eli Lilly’s reported acquisition activity.
- Broad gains across psychedelic medicine companies.
- Continued weakness in semiconductor stocks despite resilience in select technology names.
Follow TNN for daily stock market news and financial news today.
Disclaimer: This publication is intended solely for informational and journalistic purposes and does not constitute financial, investment, or legal advice. All investments involve risk, including the potential loss of capital. Investors should conduct their own research before making any investment decisions.
About The Author
